RAC1 and neoplasm: We propose that the Rho-ROCK-MLCP pathway may be specifically upregulated in tumor cells as they encounter certain extracellular cues (such as compliant environments) that prompt the downregulation of Rac1 signaling along with a concomitant up-regulation of RhoA activation.